Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setting shapes the strain: Untangling alpha-synuclein heterogeneity.

Neural regeneration research·2026
Same author

Working with worldview differences in Aotearoa: a relational approach to Te Tiriti-based governance.

Journal of the Royal Society of New Zealand·2025
Same author

Rethinking 'rare' <i>PINK1</i> Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology.

Journal of Parkinson's disease·2025
Same author

Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.

Translational neurodegeneration·2025
Same author

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.

Brain : a journal of neurology·2025
Same author

Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).

PloS one·2024

Related Experiment Video

Updated: Sep 16, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One &#945;-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.3K

Capturing α-synuclein aggregation interactors using UltraID-LIPA.

Kreesan Reddy1, Birger Victor Dieriks1

  • 1Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand; Centre for Brain Research, University of Auckland, Auckland, 1023, New Zealand.

Trends in Neurosciences
|July 11, 2025
PubMed
Summary

Researchers developed UltraID-light-inducible protein aggregation (UltraID-LIPA) to study early α-synuclein aggregation in cells. This technique identifies key proteins involved in the initial stages of synucleinopathies.

Keywords:
Parkinson’s diseasedisease heterogeneityprotein interactomeprotein misfoldingstrain diversitysynucleinopathies

More Related Videos

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.9K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.5K

Related Experiment Videos

Last Updated: Sep 16, 2025

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One &#945;-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.3K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.9K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.5K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Synucleinopathies, such as Parkinson's disease, are characterized by the aggregation of α-synuclein protein.
  • Understanding the early molecular events driving α-synuclein aggregation is crucial for developing effective therapies.

Purpose of the Study:

  • To develop a novel technique for visualizing and capturing early α-synuclein aggregation events in live cells.
  • To identify proteins that interact with α-synuclein during the initial stages of aggregation.

Main Methods:

  • The study utilized optogenetics to induce α-synuclein aggregation.
  • Proximity-based proteomics (UltraID-LIPA) was employed to capture interacting proteins in close proximity to aggregating α-synuclein.
  • High-resolution imaging was used to analyze aggregation events in live cells.

Main Results:

  • The UltraID-LIPA system successfully captured early aggregation events with high resolution.
  • The technique identified several known and novel endolysosomal proteins that interact with α-synuclein during early aggregation.
  • This implicates the endolysosomal pathway in the early pathogenesis of synucleinopathies.

Conclusions:

  • UltraID-LIPA provides a robust framework for dissecting early pathogenic mechanisms in synucleinopathies.
  • The findings offer new insights into the molecular players involved in the initial stages of α-synuclein aggregation.
  • This technique can guide future innovations in understanding and treating synucleinopathies.